Cervical Dysplasia Global Clinical Trials Review, H2, 2015

Date: July 15, 2015
Pages: 89
Price:
US$ 2,500.00 US$ 2,000.00
Offer valid until December 31, 2016!
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: C61127FC432EN
Leaflet:

Download PDF Leaflet

Cervical Dysplasia Global Clinical Trials Review, H2, 2015

SUMMARY

GlobalData's clinical trial report, “Cervical Dysplasia Global Clinical Trials Review, H2, 2015' provides an overview of Cervical Dysplasia clinical trials scenario. This report provides top line data relating to the clinical trials on Cervical Dysplasia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

SCOPE
  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

REASONS TO BUY
  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Introduction
Cervical Dysplasia
Report Guidance
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Top Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Cervical Dysplasia to Women's Health Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Cervical Dysplasia to Women's Health Clinical Trials
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Unaccomplished Trials of Cervical Dysplasia
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Cervical Dysplasia Therapeutics Clinical Trials
Prominent Drugs
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
GenoLac BL Corporation
Clinical Trial Overview of GenoLac BL Corporation
AnGes MG, Inc.
Clinical Trial Overview of AnGes MG, Inc.
Merck Sharp & Dohme Corp. (Inactive)
Clinical Trial Overview of Merck Sharp & Dohme Corp. (Inactive)
Merck & Co., Inc.
Clinical Trial Overview of Merck & Co., Inc.
Kirax Corporation
Clinical Trial Overview of Kirax Corporation
Inovio Pharmaceuticals, Inc.
Clinical Trial Overview of Inovio Pharmaceuticals, Inc.
CEL-SCI Corporation
Clinical Trial Overview of CEL-SCI Corporation
Bioleaders Corporation
Clinical Trial Overview of Bioleaders Corporation
Eisai Co., Ltd.
Clinical Trial Overview of Eisai Co., Ltd.
Akela Pharma Inc. (Inactive)
Clinical Trial Overview of Akela Pharma Inc. (Inactive)
Clinical Trial Overview of Top Institutes / Government
Maastricht University Medical Center
Clinical Trial Overview of Maastricht University Medical Center
Medical University of Vienna
Clinical Trial Overview of Medical University of Vienna
The National Institute of Allergy and Infectious Diseases
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases
The University of Tokyo Hospital
Clinical Trial Overview of The University of Tokyo Hospital
Center for Genetic Engineering and Biotechnology
Clinical Trial Overview of Center for Genetic Engineering and Biotechnology
Centre Hospitalier Regional Universitaire de Tours
Clinical Trial Overview of Centre Hospitalier Regional Universitaire de Tours
Chiang Mai University
Clinical Trial Overview of Chiang Mai University
Christine Fromer-Stiftung
Clinical Trial Overview of Christine Fromer-Stiftung
Dana-Farber Cancer Institute, Inc.
Clinical Trial Overview of Dana-Farber Cancer Institute, Inc.
Department of Health, South Africa
Clinical Trial Overview of Department of Health, South Africa
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

LIST OF TABLES

Cervical Dysplasia Therapeutics, Global, Clinical Trials by Region, 2015
Cervical Dysplasia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015
Cervical Dysplasia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015
Cervical Dysplasia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015
Cervical Dysplasia Therapeutics Clinical Trials, Europe, Top Five Countries, 2015
Cervical Dysplasia Therapeutics Clinical Trials, North America, Top Countries, 2015
Cervical Dysplasia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015
Cervical Dysplasia Therapeutics Clinical Trials, Central and South America, Top Countries, 2015
Proportion of Cervical Dysplasia to Women's Health Clinical Trials, G7 Countries (%), 2015
Cervical Dysplasia Therapeutics, G7 Countries, Clinical Trials by Phase, 2015
Cervical Dysplasia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015
Proportion of Cervical Dysplasia to Women's Health Clinical Trials, E7 Countries (%), 2015
Cervical Dysplasia Therapeutics, Global, Clinical Trials by Phase, 2015
Cervical Dysplasia Therapeutics, Global, Clinical Trials In Progress by Phase 2015
Cervical Dysplasia Therapeutics, Global, Clinical Trials by Trial Status, 2015
Cervical Dysplasia Therapeutics Clinical Trials, Global, by End Point Status, 2015
Cervical Dysplasia Therapeutics, Global, Withdrawn Clinical Trials, 2015
Cervical Dysplasia Therapeutics, Global, Terminated Clinical Trials, 2015
Cervical Dysplasia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
Cervical Dysplasia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015
Cervical Dysplasia Therapeutics Clinical Trials, Global, Key Sponsors, 2015
Cervical Dysplasia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015
Cervical Dysplasia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015
Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by GenoLac BL Corporation, 2015
Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by AnGes MG, Inc., 2015
Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck Sharp & Dohme Corp. (Inactive), 2015
Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2015
Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Kirax Corporation, 2015
Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Inovio Pharmaceuticals, Inc., 2015
Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by CEL-SCI Corporation, 2015
Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Bioleaders Corporation, 2015
Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2015
Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Akela Pharma Inc. (Inactive), 2015
Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Maastricht University Medical Center, 2015
Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2015
Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2015
Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Tokyo Hospital, 2015
Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Center for Genetic Engineering and Biotechnology, 2015
Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Regional Universitaire de Tours, 2015
Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Chiang Mai University, 2015
Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Christine Fromer-Stiftung, 2015
Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, Inc., 2015
Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, South Africa, 2015

LIST OF FIGURES

Cervical Dysplasia Therapeutics, Global, Clinical Trials by Region (%), 2015
Cervical Dysplasia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015
Cervical Dysplasia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015
Cervical Dysplasia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015
Cervical Dysplasia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015
Cervical Dysplasia Therapeutics Clinical Trials, North America, Top Countries (%), 2015
Cervical Dysplasia Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015
Cervical Dysplasia Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015
Proportion of Cervical Dysplasia to Women's Health Clinical Trials, G7 Countries (%), 2015
Cervical Dysplasia Therapeutics, G7 Countries, Clinical Trials by Phase, 2015
Cervical Dysplasia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015
Proportion of Cervical Dysplasia to Women's Health Clinical Trials, E7 Countries (%), 2015
Cervical Dysplasia Therapeutics, Global, Clinical Trials by Phase (%), 2015
Cervical Dysplasia Therapeutics, Global, Clinical Trials In Progress by Phase, 2015
Cervical Dysplasia Therapeutics, Global, Clinical Trials by Trial Status, 2015
Cervical Dysplasia Therapeutics Clinical Trials, Global, by End Point Status, 2015
Cervical Dysplasia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
Cervical Dysplasia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015
Cervical Dysplasia Therapeutics Clinical Trials, Global, Key Sponsors, 2015
Cervical Dysplasia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015
Cervical Dysplasia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015
GlobalData Methodology

COMPANIES MENTIONED

GenoLac BL Corporation
AnGes MG, Inc.
Merck & Co., Inc.
Kirax Corporation
Inovio Pharmaceuticals, Inc.
CEL-SCI Corporation
Bioleaders Corporation
Eisai Co., Ltd.
Skip to top


Ask Your Question

Cervical Dysplasia Global Clinical Trials Review, H2, 2015
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: